Health Economics Policy and Law

Papers
(The TQCC of Health Economics Policy and Law is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
HEP volume 17 issue 4 Cover and Back matter17
The contaminated blood scandal in England: exploring the social harms experienced by infected and affected individuals16
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group14
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis12
Priority setting for health equality – searching for an ethical framework12
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges10
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals9
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?9
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 20228
Out with the old…7
Judicial claims for access to treatment in the private health insurance sector in Brazil7
HEP volume 17 issue 2 Cover and Front matter7
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-197
Managed competition in Colombia: convergence of public and private insurance and delivery6
Politics in all policies: how healthcare is shaped by political (in)action6
Saving children's lives through interventions: a quasi-experimental analysis of GAVI6
A review of heath economic evaluation practice in the Netherlands: are we moving forward?5
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?5
Exploring differences between public and private providers in primary care: findings from a large Swedish region4
Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination4
Fair processes for financing universal health coverage?4
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system4
Healthcare reform in the Netherlands: after 15 years of regulated competition4
An examination of health care efficiency in Canada: a two-stage semi-parametric approach4
Neighborhood inequalities and the decline of infant mortality in São Paulo4
The state of American health coverage: the 2022 elections and the Affordable Care Act4
Making care primary: a renewed investment into primary care4
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework3
HEP volume 17 issue 1 Cover and Front matter3
Has regional decentralisation saved lives during the COVID-19 pandemic?3
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden3
The roads to managed competition for mixed public–private health systems: a conceptual framework3
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute3
… and in with the new3
Medical marijuana laws and mental health in the United States3
Primary care as determinant of COVID-19 and influenza vaccine uptake3
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?3
Political determinants of health: (re) examining the role of governance in reducing maternal mortality3
0.040462017059326